InvestorsHub Logo
Followers 138
Posts 23724
Boards Moderated 0
Alias Born 04/08/2004

Re: None

Monday, 02/22/2021 4:43:58 PM

Monday, February 22, 2021 4:43:58 PM

Post# of 470004
TODAY from the Michael J. Fox Foundation

Tracking Drug that Improves Cognition: Anavex Life Sciences is testing a drug with the potential to slow or stop Parkinson’s. ANAVEX2-73 activates the sigma-1 receptor protein, which protects brain cells from harmful stress and toxic protein buildup. After ANAVEX2-73 showed improvement on thinking and memory in people with Parkinson’s disease dementia, the company is studying how the drug works in the brain through imaging scans and blood tests. This can help guide future trials. We previously funded Anavex for laboratory studies toward development of ANAVEX2-73.



https://www.michaeljfox.org/news/what-we-fund-11m-projects-investigating-new-parkinsons-treatments-and-learning-more-about

Good luck and GOD bless,
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News